Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Arthritis Rheum ; 62(6): 1718-22, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20155836

RESUMEN

OBJECTIVE: Systemic lupus erythematosus (SLE) is independently associated with accelerated atherosclerosis and premature arterial stiffening. Asymmetric dimethylarginine (ADMA) and homocysteine are mechanistically interrelated mediators of endothelial dysfunction and correlates of atherosclerosis in the general population. The aim of this study was to assess the relationship of ADMA and homocysteine to subclinical vascular disease in patients with SLE. METHODS: One hundred twenty-five patients with SLE who were participating in a study of cardiovascular disease underwent clinical and laboratory assessment, carotid artery ultrasonography to detect atherosclerosis, and radial artery applanation tonometry to measure arterial stiffness. RESULTS: Neither ADMA nor homocysteine correlated with the presence or extent of carotid atherosclerosis. In contrast, ADMA was significantly related to the arterial stiffness index. Independent correlates of arterial stiffening included the ADMA concentration, the presence of diabetes mellitus, older age at the time of diagnosis, longer disease duration, and the absence of anti-Sm or anti-RNP antibodies. A secondary multivariable analysis substituting homocysteine for ADMA demonstrated comparable relationships with arterial stiffness (r(2) = 0.616 for homocysteine and r(2) = 0.595 for ADMA). CONCLUSION: ADMA and homocysteine are biomarkers for and may be mediators of premature arterial stiffening in patients with SLE. Because arterial stiffness has independent prognostic value for cardiovascular morbidity and mortality, its predictors may identify patients who are at increased risk of cardiovascular disease.


Asunto(s)
Envejecimiento/metabolismo , Arginina/análogos & derivados , Arterias Carótidas/patología , Homocisteína/sangre , Lupus Eritematoso Sistémico/metabolismo , Enfermedades Vasculares/metabolismo , Adulto , Envejecimiento/patología , Arginina/sangre , Arterias Carótidas/metabolismo , Femenino , Humanos , Lupus Eritematoso Sistémico/complicaciones , Lupus Eritematoso Sistémico/patología , Masculino , Persona de Mediana Edad , Análisis Multivariante , Selección de Paciente , Pronóstico , Índice de Severidad de la Enfermedad , Enfermedades Vasculares/complicaciones , Enfermedades Vasculares/patología
3.
3 Biotech ; 8(2): 119, 2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-29430380

RESUMEN

The tolerance of the pentose-fermenting yeast Meyerozyma guilliermondii to the inhibitors released after the biomass hydrolysis, such as acetic acid and furfural, was surveyed. We first verified the effects of acetic acid and cell concentrations and initial pH on the growth of a M. guilliermondii strain in a semi-synthetic medium containing acetic acid as the sole carbon source. Second, the single and combined effects of furfural, acetic acid, and sugars (xylose, arabinose, and glucose) on the sugar uptake, cell growth, and ethanol production were also analysed. Growth inhibition occurred in concentrations higher than 10.5 g l-1 acetic acid and initial pH 3.5. The maximum specific growth rate (µ) was 0.023 h-1 and the saturation constant (ks) was 0.75 g l-1 acetic acid. Initial cell concentration also influenced µ. Acetic acid (initial concentration 5 g l-1) was co-consumed with sugars even in the presence of 20 mg l-1 furfural without inhibition to the yeast growth. The yeast grew and fermented sugars in a sugar-based medium with acetic acid and furfural in concentrations much higher than those usually found in hemicellulosic hydrolysates.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA